申请人:Wang Tao
公开号:US20130095066A1
公开(公告)日:2013-04-18
The disclosure provides compounds of formula I, including pharmaceutically acceptable salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
该披露提供了公式I的化合物,包括药物可接受的盐,以及使用这些化合物的组合物和方法。这些化合物对丙型肝炎病毒(HCV)具有活性,可能有助于治疗感染HCV的人。